Photo from wikipedia
Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years, non-platinum-based scaffolds have been exploited as viable candidates for the exploitation of anticancer agents with… Click to show full abstract
Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years, non-platinum-based scaffolds have been exploited as viable candidates for the exploitation of anticancer agents with potentially lower toxicity than the widely used cisplatin analogues. This review highlights the latest advances in developing iridium(III) complexes as anticancer agents that act particularly via targeting apoptotic cell death in cancer cells.
Keywords:
iridium iii;
apoptotic cell;
targeting apoptotic;
iii complexes;
death cancer;
cell death
Journal Title: Molecules
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Molecules
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!